The Latest in Hypertension

Clinical Endocrinology News

Artificial intelligence poised to change paradigm of CV risk prevention

August 28, 2022

Clinical Endocrinology News

DANCAVAS misses primary endpoint but hints at benefit from comprehensive CV screening

August 27, 2022

Clinical Endocrinology News

Dapagliflozin’s HFpEF benefit recasts heart failure treatment: DELIVER

August 27, 2022

Clinical Endocrinology News

TIME: CV events similar with evening or morning dose of BP meds

August 26, 2022

Hypertension

Clinical Endocrinology News

Sacubitril/valsartan shows cognitive safety in heart failure: PERSPECTIVE

August 26, 2022

Hypertension

Clinical Endocrinology News

Secondary CV prevention benefit from polypill promises global health benefit

August 26, 2022

Clinical Endocrinology News

‘Conservative’ USPSTF primary prevention statin guidance finalized

August 24, 2022

Clinical Endocrinology News

Barcelona beckons for first hybrid ESC Congress

August 24, 2022

Clinical Endocrinology News

AHA statement outlines symptoms of common heart diseases

August 22, 2022

Clinical Endocrinology News

Rich or poor, educated or not, all face risk for hypertension

August 22, 2022

Clinical Endocrinology News

Gut metabolites may explain red meat–ASCVD link

August 15, 2022

Clinical Endocrinology News

More evidence salt substitutes lower risk of CVD and death

August 12, 2022

Hypertension

Clinical Endocrinology News

Social isolation, loneliness tied to death, MI, stroke: AHA

August 5, 2022

Clinical Endocrinology News

Onset and awareness of hypertension varies by race, ethnicity

August 5, 2022

Clinical Endocrinology News

‘Staggering’ CVD rise projected in U.S., especially in minorities

August 4, 2022